Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9224837rdf:typepubmed:Citationlld:pubmed
pubmed-article:9224837lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9224837lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9224837lifeskim:mentionsumls-concept:C0039729lld:lifeskim
pubmed-article:9224837lifeskim:mentionsumls-concept:C0205098lld:lifeskim
pubmed-article:9224837lifeskim:mentionsumls-concept:C0220839lld:lifeskim
pubmed-article:9224837lifeskim:mentionsumls-concept:C0085845lld:lifeskim
pubmed-article:9224837lifeskim:mentionsumls-concept:C1441616lld:lifeskim
pubmed-article:9224837lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9224837lifeskim:mentionsumls-concept:C0054444lld:lifeskim
pubmed-article:9224837pubmed:issue1lld:pubmed
pubmed-article:9224837pubmed:dateCreated1997-9-12lld:pubmed
pubmed-article:9224837pubmed:abstractTextTopographical and quantitative features of medial thalamic neurons in which aspartate (ASP) or glutamate (GLU) might act as neurotransmitters were investigated in the rat. The calcium-binding protein calbindin D-28k (CB) was exploited as a marker of neuronal subsets, thus allowing us to study also the relationships between the CB-containing neurons and those immunoreactive to excitatory amino acids. Double immunocytochemistry of ASP and CB or GLU and CB was performed in 40-microm-thick sections. The three markers were distributed in the thalamic midline, mediodorsal, anterior intralaminar and ventromedial nuclei, with regional variations. ASP-immunoreactive neurons appeared more numerous than the GLU-immunoreactive ones throughout these structures; ASP-CB or GLU-CB double-immunostained neurons were evident. ASP-, GLU- and CB-immunoreactive cells were then quantitatively evaluated in 5-microm-thick consecutive sections. Interindividual variations and different anti-ASP and anti-GLU antibodies did not result in significant differences. ASP and GLU were not co-localized. Single ASP- or GLU-immunoreactive neurons accounted for 60% of the total number of immunostained cells, and single ASP-immunopositive cells represented more than half of these neurons. Among the CB-immunoreactive cells (40% of the total), half were double immunostained; the proportion of double CB-ASP-immunopositive neurons was sevenfold higher than that of the CB-GLU-immunoreactive ones. These results indicate that ASP may act as excitatory neurotransmitter in a relatively high proportion of medial thalamic neurons, in which ASP frequently coexists with CB. Approximately 50% of the CB-immunoreactive cells did not contain either ASP or GLU, suggesting that some medial thalamic neurons may utilize a different neurotransmitter.lld:pubmed
pubmed-article:9224837pubmed:languageenglld:pubmed
pubmed-article:9224837pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9224837pubmed:citationSubsetIMlld:pubmed
pubmed-article:9224837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9224837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9224837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9224837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9224837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9224837pubmed:statusMEDLINElld:pubmed
pubmed-article:9224837pubmed:monthJunlld:pubmed
pubmed-article:9224837pubmed:issn0014-4819lld:pubmed
pubmed-article:9224837pubmed:authorpubmed-author:BentivoglioMMlld:pubmed
pubmed-article:9224837pubmed:authorpubmed-author:SpreaficoRRlld:pubmed
pubmed-article:9224837pubmed:authorpubmed-author:FrassoniCClld:pubmed
pubmed-article:9224837pubmed:issnTypePrintlld:pubmed
pubmed-article:9224837pubmed:volume115lld:pubmed
pubmed-article:9224837pubmed:ownerNLMlld:pubmed
pubmed-article:9224837pubmed:authorsCompleteYlld:pubmed
pubmed-article:9224837pubmed:pagination95-104lld:pubmed
pubmed-article:9224837pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:meshHeadingpubmed-meshheading:9224837-...lld:pubmed
pubmed-article:9224837pubmed:year1997lld:pubmed
pubmed-article:9224837pubmed:articleTitleGlutamate, aspartate and co-localization with calbindin in the medial thalamus. An immunohistochemical study in the rat.lld:pubmed
pubmed-article:9224837pubmed:affiliationDipartimento di Neurofisiologia, Istituto Nazionale Neurologico C. Besta, Milano, Italy.lld:pubmed
pubmed-article:9224837pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9224837pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9224837lld:pubmed